Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $125,965 - $170,643
-1,063 Reduced 34.35%
2,032 $246,000
Q1 2023

May 08, 2023

SELL
$135.66 - $197.02 $2,306 - $3,349
-17 Reduced 0.55%
3,095 $475,000
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $64,161 - $113,841
542 Added 21.09%
3,112 $558,000
Q1 2022

May 10, 2022

BUY
$126.46 - $235.05 $325,002 - $604,078
2,570 New
2,570 $442,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cahill Wealth Management, LLC Portfolio

Follow Cahill Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cahill Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cahill Wealth Management, LLC with notifications on news.